Vertex pharmaceuticals inc / ma (VRTX)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09
Revenues:
Revenues:
Revenues

1,515,107

1,413,265

949,828

941,293

858,435

870,106

784,535

752,157

640,799

651,634

578,165

544,135

714,718

458,706

413,783

431,608

398,080

417,935

309,816

166,076

138,509

144,556

178,987

138,421

118,451

351,157

221,700

310,750

328,368

333,994

336,006

418,305

438,737

563,340

659,200

114,424

73,662

65,524

23,795

31,622

22,429

33,889

24,957

19,064

23,979

Costs and expenses:
Cost of sales

162,497

185,012

131,914

135,740

95,092

122,289

111,255

104,382

71,613

84,052

72,874

71,205

46,988

59,646

53,222

44,154

49,789

62,092

30,269

15,409

9,381

11,290

10,208

9,655

8,572

13,281

20,048

24,695

30,955

75,595

30,680

104,549

25,918

22,936

35,285

5,404

0

-

-

0

-

-

-

-

-

Royalty expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

836

855

1,098

860

1,293

1,691

1,451

2,926

2,737

3,976

7,645

6,904

8,983

7,291

13,236

11,788

12,120

7,856

9,874

13,293

7,191

3,121

3,902

2,666

3,049

3,228

3,086

3,367

3,647

3,712

3,267

3,576

Research and development expenses

448,528

480,011

555,948

379,091

339,490

437,881

330,510

337,532

310,553

306,664

454,947

289,451

273,563

248,452

272,370

271,008

255,860

310,181

246,284

223,858

215,599

201,463

190,939

224,487

238,617

249,609

219,442

222,455

218,095

213,109

200,161

196,544

196,371

186,438

189,052

173,604

158,612

168,888

170,434

155,082

143,012

135,230

132,132

139,331

143,581

Sales, general and administrative expenses

182,258

195,277

159,674

156,502

147,045

153,210

137,295

137,303

129,808

134,794

120,710

127,249

113,326

109,908

106,055

111,652

105,214

96,549

99,772

94,394

85,860

78,527

75,224

77,446

74,212

75,188

86,427

106,521

92,879

110,452

97,684

117,514

111,146

121,881

110,654

96,663

71,523

62,478

48,855

40,915

35,552

32,574

36,572

32,526

28,520

Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability

1,600

1,500

2,959

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring (income) expenses

-

-

-

-

-

-4

174

-62

76

387

337

3,523

9,999

224

8

343

687

1,524

1,826

2,128

-3,272

4,164

40,843

-270

6,188

27,658

12,048

776

39

194

696

594

360

992

-419

741

760

-2,257

866

2,112

780

1,957

774

1,107

2,402

Intangible asset impairment charges

-

-

-

-

-

29,000

0

0

0

0

255,340

0

0

-

-

-

-

-

-

-

-

-

-

-

-

250,600

0

0

412,900

0

0

0

0

0

105,800

0

0

-

-

-

-

7,200

-

-

-

Acquisition-related expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

7,793

Total costs and expenses

794,883

861,800

850,495

671,333

581,627

742,384

578,886

579,279

511,898

525,897

904,208

491,428

443,876

419,066

432,510

428,255

412,410

471,639

379,842

337,240

310,494

298,181

321,190

318,963

334,493

625,319

345,256

367,683

766,656

411,470

337,077

429,075

347,088

339,438

443,493

280,314

233,561

232,158

223,383

201,195

182,711

180,608

173,190

176,231

185,872

Income from operations

720,224

551,465

99,333

269,960

276,808

127,722

205,649

172,878

128,901

125,737

-326,043

52,707

270,842

39,640

-18,727

3,353

-14,330

-53,704

-70,026

-171,164

-171,985

-153,625

-142,203

-180,542

-216,042

-274,162

-123,556

-56,933

-438,288

-77,476

-1,071

-10,770

91,649

223,902

215,707

-165,890

-159,899

-166,634

-199,588

-169,573

-160,282

-146,719

-148,233

-157,167

-161,893

Interest income

12,576

12,359

17,628

18,076

15,615

13,971

10,543

8,049

5,789

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

197

77

202

1,402

523

493

484

455

327

595

1,489

2,599

Interest expense

-14,136

14,249

14,548

14,837

-14,868

18,744

18,686

18,155

16,886

-12,547

-13,574

-14,664

-16,765

-20,439

-20,140

-20,155

-20,698

-20,654

-21,134

-21,111

-21,307

-21,177

-20,384

-15,585

-15,717

-12,619

-95

-6,551

-3,465

-3,263

-4,054

-3,814

-3,891

12,430

7,059

6,962

12,001

7,686

3,951

3,683

3,955

4,562

1,927

3,325

3,378

Other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

53,472

-

-

-

-

-

-

-

-868

-8,115

-2,220

-5,598

-6,595

-5,911

-27,234

-1,489

-1,847

-

-

-

Other (expense) income, net

-61,130

127,375

-31,747

53,939

42,610

-90,452

-60,995

53,819

96,838

-748

-77,553

-2,537

-544

1,105

-167

-1,219

4,411

-1,690

-1,326

1,414

-5,113

-3,792

-3,990

37,731

451

3,353

4,751

-27

-1,187

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on exchanges of convertible senior subordinated notes (due 2013)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,843

-

-12,294

-

Income before provision for income taxes

657,534

676,950

70,666

327,138

320,165

32,497

136,511

216,591

214,642

112,442

-417,170

35,506

253,533

20,306

-39,034

-18,021

-30,617

-76,048

-92,486

-190,861

-198,405

-178,594

-166,577

-158,396

-231,308

-340,253

-118,900

-63,511

-442,940

-80,772

-5,112

-14,405

87,908

210,801

200,610

-174,870

-176,096

-

-208,957

-200,006

-

-

-

-

-

Provision for income taxes

54,800

93,716

13,148

59,711

51,500

-1,492,599

8,055

10,341

-12,659

10,257

-125,903

4,337

3,985

-7,453

503

18,130

5,485

-1,379

1,330

30,131

299

2,043

3,419

693

803

-155,704

2,555

-1,799

-130,313

-2,696

21,355

20,063

32

22,660

-27,842

24,448

0

-

-

-

-

-

-

-

-

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-180,637

-169,996

-159,089

-232,111

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from discontinued operations, net of tax benefit of $0, $0 and $0, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-209

-64

-293

-346

-

-7,207

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

-

-

-

-

-

1,525,096

128,456

206,250

227,301

102,185

-291,267

31,169

249,548

27,759

-39,537

-36,151

-36,102

-74,669

-93,816

-220,992

-198,704

-180,846

-170,060

-159,382

-232,457

-184,549

-

-61,712

-312,627

-78,076

-26,467

-34,468

87,876

188,141

228,452

-199,318

-176,096

-180,392

-208,957

-200,006

-165,271

-158,644

-149,565

-171,297

-162,672

Loss attributable to noncontrolling interest

-

-

-

-

-

-25,431

-290

-1,110

17,038

1,501

-188,315

13,173

1,792

-5,186

-696

28,374

5,529

-938

1,333

-32,144

-98

-

0

0

0

-228,834

-4,530

-4,547

-4,611

-1,928

31,076

30,463

-3,714

29,512

7,342

-25,249

0

-

-

0

-

-

-

-

-

Net Income (Loss) Attributable to Parent

602,753

583,234

57,518

267,427

268,631

1,550,527

128,746

207,360

210,263

100,684

-102,952

17,996

247,756

32,945

-38,841

-64,525

-41,631

-73,731

-95,149

-188,848

-198,606

-176,656

-170,060

-159,382

-232,457

44,285

-124,132

-57,165

-308,016

-76,148

-57,543

-64,931

91,590

158,629

221,110

-174,069

-176,096

-

-208,957

-200,006

-

-

-

-

-

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-176,447

-169,996

-159,089

-232,111

-

-121,455

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-209

-64

-293

-346

-

-2,677

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss from continuing operations:
Basic (usd per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.74

-0.72

-0.68

-1.00

-

-0.53

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (usd per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.74

-0.72

-0.68

-1.00

-

-0.53

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss from discontinued operations:
Basic (usd per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.00

0.00

0.00

-

-0.01

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (usd per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.00

0.00

0.00

-

-0.01

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Earnings Per Share [Abstract]
Earnings Per Share, Basic

2.32

2.26

0.22

1.04

1.05

6.08

0.51

0.82

0.83

0.40

-0.41

0.07

1.01

0.13

-0.16

-0.26

-0.17

-0.31

-0.39

-0.78

-0.83

-0.74

-0.72

-0.68

-1.00

0.19

-0.54

-0.26

-1.43

-0.35

-0.27

-0.31

0.44

0.76

1.06

-0.85

-0.87

-0.90

-1.04

-1.00

-0.83

-0.86

-0.84

-0.99

-1.04

Earnings Per Share, Diluted

2.29

2.23

0.22

1.03

1.03

5.97

0.50

0.80

0.81

0.39

-0.41

0.07

0.99

0.13

-0.16

-0.26

-0.17

-0.31

-0.39

-0.78

-0.83

-0.74

-0.72

-0.68

-1.00

0.19

-0.54

-0.26

-1.43

-0.35

-0.27

-0.31

0.43

0.74

1.02

-0.85

-0.87

-0.90

-1.04

-1.00

-0.83

-0.86

-0.84

-0.99

-1.04

Shares used in per share calculations:
Weighted Average Number of Shares Outstanding, Basic

259,815

258,003

256,946

256,154

255,695

254,868

254,905

254,135

253,231

251,557

250,268

247,521

246,024

245,454

244,920

244,482

243,831

243,029

241,969

240,757

239,493

238,396

236,137

233,808

232,887

231,264

230,505

222,053

215,421

214,607

213,767

211,344

208,018

206,758

206,002

204,413

202,329

201,355

200,887

200,397

198,935

185,492

178,735

172,563

155,860

Weighted Average Number of Shares Outstanding, Diluted

263,515

262,108

260,473

259,822

260,175

259,812

259,788

258,584

258,526

256,804

250,268

251,635

248,700

247,757

244,920

244,482

243,831

243,029

241,969

240,757

239,493

238,396

236,137

233,808

232,887

235,717

230,505

222,053

215,421

214,607

213,767

211,344

219,264

217,602

219,349

204,413

202,329

201,355

200,887

200,397

198,935

185,492

178,735

172,563

155,860

Product revenues, net
Revenues

1,515,107

1,413,265

949,828

940,380

857,253

868,173

782,511

749,912

637,729

621,228

549,642

513,988

480,622

453,882

409,689

425,651

394,410

406,550

302,511

160,388

130,875

124,942

137,099

122,319

103,461

128,822

186,653

254,789

267,381

281,309

303,501

373,273

375,375

456,759

419,595

74,535

0

-

-

0

-

-

-

-

-

Collaborative and royalty revenues
Revenues

0

0

0

913

1,182

1,933

2,024

2,245

3,070

30,406

28,523

30,147

234,096

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalty revenues
Revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

3,887

3,835

5,282

3,596

6,331

5,759

5,077

6,792

8,785

8,386

13,015

10,733

36,887

27,012

49,120

43,573

43,451

25,586

33,480

38,981

25,405

8,539

10,010

6,061

8,402

8,173

7,262

6,407

8,429

7,834

5,917

6,140

Collaborative revenues
Revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

937

259

675

74

5,054

1,546

611

842

10,829

33,502

3,087

4,257

185,448

8,035

6,841

17,414

9,234

6,919

11,552

24,381

81,176

231,066

29,879

67,601

57,122

15,622

24,360

16,022

25,460

17,123

13,147

17,839